phenyl acetate has been researched along with Bone Neoplasms in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 9 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, HP; Canon, J; Chen, A; Chow, D; Duquette, J; Eksterowicz, J; Fox, BM; Fu, J; Gonzalez, AZ; Houze, J; Huang, X; Jin, L; Li, Y; Li, Z; Ling, Y; Lo, MC; Long, AM; McGee, LR; McIntosh, J; Medina, JC; Oliner, JD; Olson, SH; Osgood, T; Rew, Y; Saiki, AY; Shaffer, P; Sun, D; Wortman, S; Yakowec, P; Yan, X; Ye, Q; Yu, D; Zhao, X; Zhou, J | 1 |
Castanheira, L; Celis, JP; Chakar, C; Changotade, S; Felgueiras, HP; Henriques, M; Lutomski, D; Migonney, V; Naaman, N; Oughlis, S; Poirier, F; Ponthiaux, P; Rocha, LA; Younes, R | 1 |
Anner, P; Beheshti, M; Hacker, M; Haug, AR; Karanikas, G; Mitterhauser, M; Polanec, SH; Reiterits, B; Spick, C; Wadsak, W | 1 |
Chan, GC; Chiang, AK; Liu, AP; See, QW; Wong, KN | 1 |
Akers, WJ; Cenci, S; Civitelli, R; D'avignon, A; Fontana, F; Ge, X; Hathi, D; Shoghi, KI; Shokeen, M; Su, X; Weilbaecher, KN; Xiang, J | 1 |
Liang, QD; Liu, SP; Tao, JG; Wan, G; Wang, GD; Zhao, HX | 1 |
Lindholm, P; Minn, H; Seppänen, M | 1 |
Blesa, JM; Candel, VA | 1 |
Chen, S; Cheng, TK; Ho, CL; Leung, YL | 1 |
Eary, JF; Hackenbracht, JA; Higano, CS; Link, JM; Mankoff, DA; Montgomery, RB; Muzi, M; Rezvani, BB; Yu, EY | 1 |
Bergh, S; Boerner, AR; Brunkhorst, T; Fricke, E; Hofmann, M; Karstens, JH; Knapp, WH; Machtens, S; Meyer, GJ; van den Hoff, J | 1 |
Akino, H; Aoki, Y; Fujibayashi, Y; Kaneda, T; Matsuta, Y; Miwa, Y; Nakai, M; Okazawa, H; Oyama, N; Shioyama, R; Tanase, K; Yokoyama, O; Yonekura, Y | 1 |
Akino, H; Kanamaru, H; Muramoto, S; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yamamoto, K; Yonekura, Y | 1 |
Edwards, B; Goeckeler, WF; Simon, J; Troutner, DE; Volkert, WA; Wilson, D | 1 |
Anger, HO; Van Dyke, DC; Verdon, TA; Yano, Y | 1 |
3 trial(s) available for phenyl acetate and Bone Neoplasms
Article | Year |
---|---|
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.
Topics: Acetates; Bone Neoplasms; Carbon; Docetaxel; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Treatment Outcome | 2011 |
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Topics: Acetates; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
11C-acetate PET imaging of prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
12 other study(ies) available for phenyl acetate and Bone Neoplasms
Article | Year |
---|---|
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres.
Topics: Acetates; Animals; Antineoplastic Agents; Bone Neoplasms; Carboxylic Acids; Cell Proliferation; Cells, Cultured; Crystallography, X-Ray; Drug Design; Female; Humans; Hydrogen Bonding; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Myocytes, Smooth Muscle; Osteosarcoma; Piperidones; Protein Binding; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-mdm2; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Biotribocorrosion (tribo-electrochemical) characterization of anodized titanium biomaterial containing calcium and phosphorus before and after osteoblastic cell culture.
Topics: Acetates; Alkaline Phosphatase; Bone Neoplasms; Calcium Compounds; Cell Differentiation; Cell Line, Tumor; Cell Shape; Coated Materials, Biocompatible; Corrosion; Dental Materials; Electrochemistry; Friction; Glycerophosphates; Humans; Hydrophobic and Hydrophilic Interactions; Materials Testing; Osseointegration; Osteoblasts; Osteosarcoma; Oxidation-Reduction; Oxides; Phosphates; Phosphorus; Titanium | 2015 |
Detection of Bone Metastases Using 11C-Acetate PET in Patients with Prostate Cancer with Biochemical Recurrence.
Topics: Acetates; Bone Neoplasms; Carbon; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2015 |
11C-Acetate Positron Emission Tomography for Detection of Occult Metastatic Recurrence in Hepatoblastoma.
Topics: Acetates; Bone Neoplasms; Carbon Radioisotopes; Child; Female; Hepatoblastoma; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2016 |
Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma.
Topics: Acetates; Animals; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lipid Metabolism; Magnetic Resonance Imaging; Mice; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tissue Distribution | 2017 |
In vitro antitumor activity of the ethyl acetate extract of Potentilla chinensis in osteosarcoma cancer cells.
Topics: Acetates; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Drugs, Chinese Herbal; Humans; Osteosarcoma; Potentilla | 2016 |
The role of PET/CT and current challenges in prostate cancer management.
Topics: Acetates; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
PSA decrease with fulvestrant acetate in a hormone-resistant metastatic prostate cancer patient.
Topics: Acetates; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Compassionate Use Trials; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Drugs, Investigational; Estradiol; Fulvestrant; Humans; Injections, Intramuscular; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Retreatment | 2010 |
PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate | 2011 |
[Pet imaging in prostate cancer].
Topics: Acetates; Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2006 |
153Sm radiotherapeutic bone agents.
Topics: Acetates; Bone Neoplasms; Chromatography, High Pressure Liquid; Humans; Ligands; Radioisotopes; Samarium | 1986 |
Cyclotron-produced 157Dy compared with 18F for bone scanning using the whole-body scanner and scintillation camera.
Topics: Acetates; Adult; Animals; Bone and Bones; Bone Diseases; Bone Neoplasms; Calcium; Dogs; Dysprosium; Ethylenediamines; Female; Femur; Fluorine; Half-Life; Haplorhini; Humans; Kidney; Liver; Lung; Lung Neoplasms; Male; Muscles; Nuclear Reactors; Radioisotopes; Radiometry; Radionuclide Imaging; Rats; Spectrum Analysis; Spleen; Sternum; Terbium; Whole-Body Counting | 1971 |